Eun Joo Song

Dr. Eun Joo Song

Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul 03760, Korea
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2002 in Cell
Verified
Journal Article
Closed access
JJJoo-Won Jeong
Joo-Won Jeong
MBMoon-Kyoung Bae
Moon-Kyoung Bae
MAMee-Young Ahn
Mee-Young Ahn
SKSe-Hee Kim
Se-Hee Kim
TSTae-Kwon Sohn
Tae-Kwon Sohn
KKKyu-Won Kim
Kyu-Won Kim

9 November 2020 in Archives of Pharmacal Research
Verified
Journal Article
Closed access
PDF file
JPJinyoung Park
Jinyoung Park
JCJinhong Cho
Jinhong Cho
ESEun Joo Song
Eun Joo Song

1 December 2004 in Cell
Verified
Journal Article
Closed access
BJBong-Gun Ju
Bong-Gun Ju
DSDerek Solum
Derek Solum
ESEun Joo Song
Eun Joo Song
KLKong-Joo Lee
Kong-Joo Lee
DRDavid W. Rose
David W. Rose
MRMichael G. Rosenfeld
Michael G. Rosenfeld

1 July 2010 in Genes & Development
Verified
Journal Article
Open access
PDF file
ESEun Joo Song
Eun Joo Song
SWShannon L. Werner
Shannon L. Werner
JNJakob Neubauer
Jakob Neubauer
FSFrank Stegmeier
Frank Stegmeier
JAJulie L Aspden
Julie L Aspden
MRMichael Rape
Michael Rape
The spliceosome, a dynamic assembly of proteins and RNAs, catalyzes the excision of intron sequences from nascent mRNAs. Recent work has suggested that the activity and composition of the spliceosome are regulated by ubiquitination, but the underlying mechanisms have not been elucidated. Here, we report that the spliceosomal Prp19 complex modifies Prp3, a component of the U4 snRNP, with nonproteolytic K63-linked ubiquitin chains. The K63-linked chains increase the affinity of Prp3 for the U5 snRNP component Prp8, thereby allowing for the stabilization of the U4/U6.U5 snRNP. Prp3 is deubiquitinated by Usp4 and its substrate targeting factor, the U4/U6 recycling protein Sart3, which likely facilitates ejection of U4 proteins from the spliceosome during maturation of its active site. Loss of Usp4 in cells interferes with the accumulation of correctly spliced mRNAs, including those for α-tubulin and Bub1, and impairs cell cycle progression. We propose that the reversible ubiquitination of spliceosomal proteins, such as Prp3, guides rearrangements in the composition of the spliceosome at distinct steps of the splicing reaction.

1 January 2003 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
YGYoung-Hwa Goo
Young-Hwa Goo
YSYoung Chang Sohn
Young Chang Sohn
DKDae-Hwan Kim
Dae-Hwan Kim
SKSeung-Whan Kim
Seung-Whan Kim
MKMin-Jung Kang
Min-Jung Kang
JLJae Woon Lee
Jae Woon Lee
Many transcription coactivators interact with nuclear receptors in a ligand- and C-terminal transactivation function (AF2)-dependent manner. These include activating signal cointegrator 2 (ASC-2), a recently isolated transcriptional coactivator molecule, which is amplified in human cancers and stimulates transactivation by nuclear receptors and numerous other transcription factors. In this report, we show that ASC-2 belongs to a steady-state complex of approximately 2 MDa (ASC-2 complex [ASCOM]) in HeLa nuclei. ASCOM contains retinoblastoma-binding protein RBQ-3, α/β-tubulins, and trithorax group proteins ALR-1, ALR-2, HALR, and ASH2. In particular, ALR-1/2 and HALR contain a highly conserved 130- to 140-amino-acid motif termed the SET domain, which was recently implicated in histone H3 lysine-specific methylation activities. Indeed, recombinant ALR-1, HALR, and immunopurified ASCOM exhibit very weak but specific H3-lysine 4 methylation activities in vitro, and transactivation by retinoic acid receptor appears to involve ligand-dependent recruitment of ASCOM and subsequent transient H3-lysine 4 methylation of the promoter region in vivo. Thus, ASCOM may represent a distinct coactivator complex of nuclear receptors. Further characterization of ASCOM will lead to a better understanding of how nuclear receptors and other transcription factors mediate transcriptional activation.

25 September 2009 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
NHNa Rae Hwang
Na Rae Hwang
SYSeung-Hee Yim
Seung-Hee Yim
YKYoung Mee Kim
Young Mee Kim
JJJaeho Jeong
Jaeho Jeong
ESEun Joo Song
Eun Joo Song
KLKong-Joo Lee
Kong-Joo Lee
Knowledge of the cellular targets of ROS (reactive oxygen species) and their regulation is an essential prerequisite for understanding ROS-mediated signalling. GAPDH (glyceraldehyde-3-phosphate dehydrogenase) is known as a major target protein in oxidative stresses and becomes thiolated in its active site. However, the molecular and functional changes of oxidized GAPDH, the inactive form, have not yet been characterized. To examine the modifications of GAPDH under oxidative stress, we separated the oxidation products by two-dimensional gel electrophoresis and identified them using nanoLC-ESI-q-TOF MS/MS (nano column liquid chromatography coupled to electrospray ionization quadrupole time-of-flight tandem MS). Intracellular GAPDH subjected to oxidative stress separated into multiple acidic spots on two-dimensional gel electrophoresis and were identified as cysteine disulfide and cysteic acids on Cys152 in the active site. We identified the interacting proteins of oxidized inactive GAPDH as p54nrb (54 kDa nuclear RNA-binding protein) and PSF (polypyrimidine tract-binding protein-associated splicing factor), both of which are known to exist as heterodimers and bind to RNA and DNA. Interaction between oxidized GAPDH and p54nrb was abolished upon expression of the GAPDH active site mutant C152S. The C-terminal of p54nrb binds to GAPDH in the cytosol in a manner dependent on the dose of hydrogen peroxide. The GAPDH–p54nrb complex enhances the intrinsic topoisomerase I activation by p54nrb–PSF binding. These results suggest that GAPDH exerts other functions beyond glycolysis, and that oxidatively modified GAPDH regulates its cellular functions by changing its interacting proteins, i.e. the RNA splicing by interacting with the p54nrb–PSF complex.